Abeona Therapeutics Inc
ABEO
Get informed when a big investor buys or sells
+ FollowMarket Cap$347.1M
Close$
$0.27
95.6% downside
Current Fair Value
95.6% downsideOvervalued by 95.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $347.10 Million |
|---|---|
| Enterprise Value | $310.74 Million |
| Dividend Yield | $3706.25 (-) |
| Earnings per Share | $1.34 |
| Beta | 1.34 |
| Outstanding Shares | 57,048,385 |
Return
| Return on Equity | -49.11% |
|---|---|
| Return on Assets | -35.03% |
| Return on Invested Capital | -159.18% |
Valuation & Multiples
| P/E Ratio | -5.36 |
|---|---|
| PEG | 4.53 |
| Price to Sales | - |
| Price to Book Ratio | 3.08 |
| Enterprise Value to Revenue | 12.18 |
| Enterprise Value to EBIT | -1.26 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.16 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.23
Average shareholder expectationRevenue Estimate
$12.24 M
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
$15.86 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Abeona Therapeutics Inc
CEO: Joao Siffert